世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の海洋性医薬品市場 2018-2022年

Global Marine Pharmaceuticals Market 2018-2022

 

出版社 出版年月電子版価格 ページ数
TechNavio
テクナビオ
2018年3月US$2,500
シングルユーザライセンス
108

サマリー

このレポートは世界の海洋性医薬品市場を調査したTechNavioの調査報告書です。

Report Details

About Marine Pharmaceuticals
Marine pharmaceuticals include all the drugs that are obtained from the marine source. These drugs are used for the treatment of various diseases such as cancer, heart diseases, and infections.

Technavio’s analysts forecast the Global Marine Pharmaceuticals Market to grow at a CAGR of 7.28% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global marine pharmaceuticals market. To calculate the market size, the report considers the revenue generated from the sales of oncology drugs primarily along with cardiovascular, anti-infectives, and others.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, global marine pharmaceuticals market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- GlaxoSmithKline
- Jazz Pharmaceuticals
- PharmaMar
- Seattle Genetics.

Market driver
- Special drug designations
- For a full, detailed list, view our report

Market challenge
- Regular supply of marine organisms and compounds
- For a full, detailed list, view our report

Market trend
- Marine peptides as anti-infectives
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

目次

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
- Market outline
PART 05: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 06: PIPELINE LANDSCAPE
PART 07: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 08: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 09: MARKET SEGMENTATION BY APPLICATION
- Segmentation by application
- Comparison by application
- Oncology - Market size and forecast 2017-2022
- Cardiovascular - Market size and forecast 2017-2022
- Anti-infectives - Market size and forecast 2017-2022
- Others - Market size and forecast 2017-2022
- Market opportunity by application
PART 10: MARKET SEGMENTATION BY SOURCE
- Invertebrate
- Vertebrate
- Others
PART 11: CUSTOMER LANDSCAPE
PART 12: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas - Market size and forecast 2017-2022
- EMEA - Market size and forecast 2017-2022
- APAC - Market size and forecast 2017-2022
- Key leading countries
- Market opportunity
PART 13: DECISION FRAMEWORK
PART 14: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 15: MARKET TRENDS
- Marine peptides as anti-infectives
- Research for anti-inflammatory compounds from marine sources
PART 16: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 17: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- GlaxoSmithKline
- Jazz Pharmaceuticals
- PharmaMar
- Seattle Genetics
PART 18: APPENDIX
- List of abbreviations
Exhibit 01: Marine pharmaceutical: An overview
Exhibit 02: Parent market
Exhibit 03: Global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Pipeline molecules: An overview
Exhibit 07: Key clinical trials
Exhibit 08: Market definition - Inclusions and exclusions checklist
Exhibit 09: Market size 2017
Exhibit 10: Validation techniques employed for market sizing 2017
Exhibit 11: Global marine pharmaceuticals? Market size and forecast 2017-2022 ($ millions)
Exhibit 12: Global marine pharmaceuticals - Year-over-year growth 2018-2022 (%)
Exhibit 13: Five forces analysis 2017
Exhibit 14: Five forces analysis 2022
Exhibit 15: Bargaining power of buyers
Exhibit 16: Bargaining power of suppliers
Exhibit 17: Threat of new entrants
Exhibit 18: Threat of substitutes
Exhibit 19: Threat of rivalry
Exhibit 20: Market condition - Five forces 2017
Exhibit 21: Application - Market share 2017-2022 (%)
Exhibit 22: Comparison by application
Exhibit 23: Oncology - Market size and forecast 2017-2022 ($ millions)
Exhibit 24: Oncology - Year-over-year growth 2018-2022 (%)
Exhibit 25: Cardiovascular - Market size and forecast 2017-2022 ($ millions)
Exhibit 26: Cardiovascular - Year-over-year growth 2018-2022 (%)
Exhibit 27: Anti-infectives - Market size and forecast 2017-2022 ($ millions)
Exhibit 28: Anti-infectives - Year-over-year growth 2018-2022 (%)
Exhibit 29: Others - Market size and forecast 2017-2022 ($ millions)
Exhibit 30: Others - Year-over-year growth 2018-2022 (%)
Exhibit 31: Market opportunity by application
Exhibit 32: Customer landscape
Exhibit 33: Global marine pharmaceuticals - Market share by geography 2017-2022 (%)
Exhibit 34: Regional comparison
Exhibit 35: Americas - Market size and forecast 2017-2022 ($ millions)
Exhibit 36: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 37: EMEA - Market size and forecast 2017-2022 ($ millions)
Exhibit 38: EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 39: APAC - Market size and forecast 2017-2022 ($ millions)
Exhibit 40: APAC - Year-over-year growth 2018-2022 (%)
Exhibit 41: Key leading countries
Exhibit 42: Market opportunity
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: GlaxoSmithKline - Overview
Exhibit 49: GlaxoSmithKline - Business segments
Exhibit 50: GlaxoSmithKline - Organizational developments
Exhibit 52: GlaxoSmithKline - Geographic focus
Exhibit 53: GlaxoSmithKline - Segment focus
Exhibit 54: GlaxoSmithKline - Key offerings
Exhibit 55: GlaxoSmithKline - Key customers
Exhibit 56: Jazz Pharmaceuticals - Overview
Exhibit 57: Jazz Pharmaceuticals - Organizational developments
Exhibit 58: Jazz Pharmaceuticals - Geographic focus
Exhibit 59: Jazz Pharmaceuticals - Key offerings
Exhibit 60: GlaxoSmithKline - Key customers
Exhibit 61: PharmaMar - Overview
Exhibit 62: PharmaMar - Business segments
Exhibit 63: PharmaMar - Organizational developments
Exhibit 64: PharmaMar - Geographic focus
Exhibit 65: PharmaMar - Segment focus
Exhibit 66: PharmaMar - Key offerings
Exhibit 67: PharmaMar - Key customers
Exhibit 68: Seattle Genetics - Overview
Exhibit 69: Seattle Genetics - Business segments
Exhibit 70: Seattle Genetics - Organizational developments
Exhibit 71: Seattle Genetics - Geographic focus
Exhibit 72: Seattle Genetics - Segment focus
Exhibit 73: Seattle Genetics - Key offerings
Exhibit 74: Seattle Genetics - Key customers

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る